Drug survival of biologic agents in patients with psoriatic arthritis from a medical center in southern Taiwan

• 主要な著者: Sebastian Yu (著者), Yu-Hsiang Tsao (著者), Hung-Pin Tu (著者), Cheng-Che E Lan (著者)
• フォーマット: 図書
• 出版事項: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Psoriasis is a chronic inflammatory disease involving the skin and/or joints. Till 2016, there were five biologic agents for psoriatic arthritis treatment in Taiwan: etanercept, adalimumab, golimumab, ustekinumab, and secukinumab. Although European guidelines recommend tumor necrosis fac...